Drug treatment of urolithiasis using citrate therapy

Ya.A. Dombrovskyi

Abstract


Urolithiasis - disease, morphological substrate of which is the formation of stones in the urinary tract and related changes in the urinary tract. The disease is characterized by its prevalence and a variety of etiological and pathogenetic factors. The topic of this article is devoted to the comparative characteristics of drugs used in the treatment of this disease. The main part of the article is an analysis of pharmacodynamics, efficacy, safety and expediency of using citrate drugs.


Keywords


urolithiasis; drug therapy in urolithiasis; citrate therapy

References


Europеan Urology. — 2012, August 62(2).

Türk C. (chair), Knoll T. (vice-chair), Petrik A., Sarica K., Skolarikos A., Straub M., Seitz C. European Association of Urology. Guidelines on urolithiasis. — 2013.

Руководство Европейской ассоциации урологов 2013 по уролитиазу (сокращенное изложение) // Почки. — 2013. — № 4. — С. 44-54.

Lojanapiwat B., Tanthanuch M., Pripathanont C., Ratchanon S., Srinualnad S., Taweemonkongsap T., Kanyok S., Lammongkolkul S. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy // Int. Braz. J. Urol. — 2011 Sep-Oct. — 37(5). — 611-6.

Allie-Hamdulay S., Rodgers A.L. Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalateurolithiasis: randomized, placebo-controlled trial // Urol. Res. — 2005 May. — 33(2). — 116-24. Epub 2005 May 4.

Kato Y., Yamaguchi S., Yachiku S., Nakazono S., Hori J., Wada N., Hou K. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis // Urology. — 2004 Jan. — 63(1). — 7-11; discussion 11-2.

Chen Y.T., Hsuan S.L., Jiann B.P., Chou C.C., Chang S.C., Lee Y.F., Chien M.S., Lee W.C., Tsai F.J., Liao J.W. Effects of sodium citrate on melamine-cyanuric acid mixture-induced urolithiasis in rats // Clin. Chim. Acta. — 2013 Sep 23. — 424. — 76-82. doi: 10.1016/j.cca.2013.05.016. Epub 2013 May 28.

Шпоть Е.В., Султанова Е.А. Цитратная терапия мочекаменной болезни // Фарматека. — 2012. — № 4. — С. 10-13.

Fink H.A., Akornor J.W., Garimella P.S. et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of ran-domized trials // Eur. Urol. — 2009. — 56(1). — 72-80.

Siener R., Ebert D., Nicolay C. et al. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers // Kidney Int. — 2003. — 63(3). — 1037-1043.

Siener R., Glatz S., Nicolay C. et al. The role of overweight and obesity in calcium oxalate stone formation // Obes. Res. — 2004. — 12(1). — 106-113.

Straub M., Strohmaier W.L., Berg W. et al. Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline // World J. Urol. — 2005. — 23(5). — 309-323.

Wabner C.L., Pak C.Y. Effect of orange juice consumption on urinary stone risk factors // J. Urol. — 1993. — 149(6). — 1405-1408.

Gettman M.T., Segura J.W. Struvite stones: diagnosis and current treatment concepts // J. Endourol. — 1999 Nov. — 13(9). — 653-8.

Straub M., Strohmaier W.L., Berg W. et al. Diagnosis and metaphylaxis of stone disease Consensus concept of the National Working Committee on Stone Disease for the Upcoming German Urolithiasis Guideline // World J. Urol. — 2005 Nov. — 23(5). — 309-23.

Coe F.L., Evan A., Worcester E. Kidney stone disease // J. Clin. Invest. — 2005 Oct. — 115(10). — 2598-608.

Wagner C.A., Mohebbi N. Urinary pH and stone formation // J. Nephrol. — 2010 Nov-Dec. — 23(Suppl. 16). — S165-9.

Takei K., Ito H., Masai M. et al. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria // Urol. Int. — 1998. — 61(3). — 192-5.

Ettinger B., Citron J.T., Livermore B., Dolman L.I. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not // J. Urol. — 1988 Apr. — 139(4). — 679-84.

Ohkawa M., Tokunaga S., Nakashima T. et al. Thiazide treatment for calcidiopathichypercalciuria // Br. J. Urol. — 1992 Jun. — 69(6). — 571-6.

Wilson D.R., Strauss A.L., Manuel M.A. Comparison of mcalcium nephrolithiasis // Urol. Res. — 1984. — 12. — 39-40.




DOI: https://doi.org/10.22141/2307-1257.0.1.07.2014.76551

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru